Verve Therapeutics, Inc. (VERV)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 01:33PM EDT. Market open.
| Previous Close | 6.58 |
| Open | 6.28 |
| Bid | 6.20 x 200 |
| Ask | 6.29 x 100 |
| Day's Range | 6.05 - 6.35 |
| 52 Week Range | 6.05 - 21.42 |
| Volume | |
| Avg. Volume | 1,296,924 |
| Market Cap | 521.784M |
| Beta (5Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.12 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32.13 |
ZacksWhy Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
ZacksBiotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Disc Medicine, Inc. (IRON) and Verve Therapeutics (VERV) fall on study updates.
ZacksVerve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls
Verve (VERV) stops enrollment in the phase Ib study of gene therapy candidate VERVE-10 to reduce disease-driving low-density lipoprotein cholesterol due to safety issues. Stock plunges on the news.
© 2024 Yahoo. All rights reserved.